Loss of the Cyclin-Dependent Kinase Inhibitor 1 in the Context of Brachyury-Mediated Phenotypic Plasticity Drives Tumor Resistance to Immune Attack
Duane H. Hamilton(National Institutes of Health), Claudia Palena(National Institutes of Health)
Cited by 11
Related Papers
The IL-8/IL-8R Axis: A Double Agent in Tumor Immune Resistance
|Vaccines|2016|393
Neutralization of IL-8 decreases tumor PMN-MDSCs and reduces mesenchymalization of claudin-low triple-negative breast cancer
|JCI Insight|2017|164
Simultaneous inhibition of CXCR1/2, TGF-β, and PD-L1 remodels the tumor and its microenvironment to drive antitumor immunity
|Journal for ImmunoTherapy of Cancer|2020|96